Scott Isaacs, president-elect of the American Association of Clinical Endocrinology, describes patients who lost significant weight on semaglutide while taking other medications that required dose adjustments they didn't know about
He W, Lam TK, Obici S, Rossetti L: Molecular disruption of hypothalamic nutrient sensing induces obesity
According to research published in Diabetes, Obesity and Metabolism (2023), glucagon receptor activation increases resting energy expenditure, promotes hepatic fat oxidation, and may reduce liver fat content, a meaningful benefit for patients with non-alcoholic fatty liver disease (NAFLD)
Address psychological factors Stress, anxiety, and depression can significantly impact libido, says Ryan S
Injecting while traveling: practical logistics You have your medication safely at your destination